Literature DB >> 12703541

The Ishikawa cells from birth to the present.

Masato Nishida1.   

Abstract

More than 20 years have passed since the Ishikawa cell line, a well-differentiated human endometrial adenocarcinoma cell line, was established. Because this cell line bears estrogen and progesterone receptors, the cells have been used in numerous basic research areas such as reproductive biology and molecular science, and has been distributed to more than a hundred institutes. However, even the Ishikawa cells, after long-term culture, tend to transform into undifferentiated cells. In addition, it has been reported that estrogen and progesterone receptors disappeared from the cells that I distributed. I therefore attempted to establish well-differentiated cells from the parent Ishikawa cells and to produce a new and good quality supply of this cell line. I believe that it is very important for the investigator who established a cell line to be responsible for maintaining the quality of the cells. That is why I have not deposited this cell line in any cell bank. I would like to take this opportunity to report the history of Ishikawa cells from establishment to the present.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12703541     DOI: 10.1111/j.1749-0774.2002.tb00105.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  7 in total

1.  Establishment of eighteen clones of Ishikawa cells.

Authors:  M Nishida; K Kasahara; A Oki; T Satoh; Y Arai; T Kubo
Journal:  Hum Cell       Date:  1996-06       Impact factor: 4.174

2.  Improved sensitivity in the measurement of estrogen receptor in human breast cancer.

Authors:  W L McGuire; M DeLaGarza
Journal:  J Clin Endocrinol Metab       Date:  1973-12       Impact factor: 5.958

3.  Establishment of a cell line of human endometrial adenocarcinoma in vitro.

Authors:  H Kuramoto; S Tamura; Y Notake
Journal:  Am J Obstet Gynecol       Date:  1972-12-15       Impact factor: 8.661

4.  Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.

Authors:  K S McCarty; T K Barton; B F Fetter; W T Creasman; K S McCarty
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

5.  [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors].

Authors:  M Nishida; K Kasahara; M Kaneko; H Iwasaki; K Hayashi
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1985-07

6.  Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.

Authors:  W T Creasman; K S McCarty; T K Barton; K S McCarty
Journal:  Obstet Gynecol       Date:  1980-03       Impact factor: 7.661

7.  Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.

Authors:  C E Ehrlich; P C Young; R E Cleary
Journal:  Am J Obstet Gynecol       Date:  1981-11-01       Impact factor: 8.661

  7 in total
  55 in total

1.  Dose- and Time-Dependent Transcriptional Response of Ishikawa Cells Exposed to Genistein.

Authors:  Jorge M Naciff; Zubin S Khambatta; Gregory J Carr; Jay P Tiesman; David W Singleton; Sohaib A Khan; George P Daston
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

2.  Apoptotic effects of Tian-Long compound on endometrial adenocarcinoma cells in vitro.

Authors:  Zhong-Lian Li; Syoko Morishima; Jin-Tian Tang; Yoshinori Otsuki
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

3.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

4.  Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth.

Authors:  M J Pineda; Z Lu; D Cao; J J Kim
Journal:  Horm Cancer       Date:  2015-05-15       Impact factor: 3.869

Review 5.  Human endometrial cytodifferentiation by histone deacetylase inhibitors.

Authors:  Hiroshi Uchida; Tetsuo Maruyama; Takashi Nagashima; Masanori Ono; Hirotaka Masuda; Toru Arase; Ikuko Sugiura; Maki Onouchi; Takashi Kajitani; Hironori Asada; Yasunori Yoshimura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

6.  Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.

Authors:  Yunfei Wen; Ying Wang; Anca Chelariu-Raicu; Elaine Stur; Yuan Liu; Sara Corvigno; Faith Bartsch; Lauren Redfern; Behrouz Zand; Yu Kang; Jinsong Liu; Keith Baggerly; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-07-31       Impact factor: 6.261

7.  VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells.

Authors:  T Fujisawa; J Watanabe; Y Kamata; M Hamano; H Hata; H Kuramoto
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.174

8.  Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines.

Authors:  Andrea Schröpfer; Ulrike Kammerer; Michaela Kapp; Johannes Dietl; Sonja Feix; Jelena Anacker
Journal:  BMC Cancer       Date:  2010-10-13       Impact factor: 4.430

9.  Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer.

Authors:  Noriyuki Takai; Hisashi Narahara
Journal:  Obstet Gynecol Int       Date:  2010-02-04

10.  Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.

Authors:  David Maldonado-Pérez; Pamela Brown; Kevin Morgan; Robert P Millar; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.